4//SEC Filing
TOMBESI PAOLO 4
Accession 0001209191-21-048337
CIK 0001595893other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 6:22 PM ET
Size
7.3 KB
Accession
0001209191-21-048337
Insider Transaction Report
Form 4
TOMBESI PAOLO
EVP & Chief Financial Officer
Transactions
- Award
Common Stock
2021-07-26+13,600→ 13,600 total - Award
Stock Option (right to buy)
2021-07-26+61,200→ 61,200 totalExercise: $62.63Exp: 2031-07-25→ Common Stock (61,200 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]25% of the shares vest on July 26, 2022 and 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001707648
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 6:22 PM ET
- Size
- 7.3 KB